Tricuspid regurgitation therapy

Tricuspid Regurgitation Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Tricuspid Regurgitation from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Stages
History and Symptoms
Physical Examination
Laboratory Findings
Echocardiography
Chest X Ray
Electrocardiogram
Cardiac Stress Test
Cardiac MRI
Cardiac Catheterization
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Tricuspid regurgitation therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tricuspid regurgitation therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA onTricuspid regurgitation therapy
CDC on Tricuspid regurgitation therapy
Tricuspid regurgitation therapy in the news
Blogs on Tricuspid regurgitation therapy
Directions to Hospitals Treating Tricuspid regurgitation
Risk calculators and risk factors for Tricuspid regurgitation therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In most cases, surgery is not indicated since the root problem lies with a dilated or damaged right ventricle. Medical therapy with diuretics is the mainstay of treatment. Unfortunately, this can lead to volume depletion and decreased cardiac output. Indeed, one must often accept a certain degree of symptomatic tricuspid insufficiency in order to prevent a decrease in cardiac output. Treatment with medicines to reduce cardiac afterload may also be of benefit but a similar risk of depressed cardiac output applies.